Pharmagreen Biotech Inc Watch

EX-10.2

from 8-K 6 pages Services Agreement

12/34/56

EX-10.1

from 8-K 6 pages Production and Broadcast Agreement

12/34/56

EX-10.3

from 8-K 1 page Promissory Note Issued to Oscaleta Partners LLC

12/34/56

EX-10.2

from 8-K 1 page Registration Rights Agreement Between Pharmagreen Biotech Inc. and Oscaleta Partners LLC

12/34/56

EX-10.1

from 8-K 1 page Equity Purchase Agreement Between Pharmagreen Biotech Inc. and Oscaleta Partners LLC

12/34/56

EX-10.6

from 8-K 13 pages Convertible Promissory Note

12/34/56

EX-10.5

from 8-K 11 pages Securities Purchase Agreement

12/34/56

EX-10.4

from 8-K 20 pages 10% Convertible Note

12/34/56

EX-10.3

from 8-K 20 pages Securities Purchase Agreement This Securities Purchase Agreement (This “Agreement”), Dated as of October 1, 2019, Is Entered Into by and Between Pharmagreen Biotech Inc., a Nevada Corporation (The “Company”), and Ema Financial, LLC, a Delaware Limited Liability Company (The “Purchaser” or “Holder”)

12/34/56

EX-10.2

from 8-K 13 pages Convertible Promissory Note

12/34/56

EX-10.1

from 8-K 11 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 1 page Agreement Dated September 3, 2019 With Emerging Markets Consulting, LLC

12/34/56

EX-10.3

from 8-K ~5 pages Material contract

12/34/56

EX-10.2

from 8-K ~10 pages Escrow Agreement

12/34/56

EX-10.1

from 8-K ~20 pages Stock Purchase Agreement

12/34/56

EX-10.1

from S-1 ~5 pages Marketing and Sales Distribution Agr

12/34/56